Pulmonx outlines 2026 revenue target of $90M-$92M with cost realignment and renewed U.S. sales focus
Source: SeekingAlpha
2026-03-04 18:22:59 ET
More on Pulmonx
- Pulmonx Corporation (LUNG) Q4 2025 Earnings Call Transcript
- Pulmonx GAAP EPS of -$0.25 beats by $0.14, revenue of $22.59M beats by $0.86M
- Seeking Alpha’s Quant Rating on Pulmonx
- Historical earnings data for Pulmonx
- Financial information for Pulmonx
Read the full article on Seeking Alpha
For further details see:
Pulmonx outlines 2026 revenue target of $90M-$92M with cost realignment and renewed U.S. sales focus
Pulmonx Corporation
NASDAQ: LUNG
LUNG Trading
-10.42% G/L:
$1.855 Last:
673,147 Volume:
$1.93 Open:
LUNG Latest News
LUNG Stock Data
$60,839,375
38,442,236
0.23%
38
N/A
Medical Equipment & Supplies
Healthcare
US
Redwood City
